nirogacestat
springworks therapeutics
['nirogacestat', 'defi ']
nirogacestat improved pfs versus placebo in adults with progressing desmoid tumors, according to the new data from the phase 3 defi trial presented at #esmo22. 
OBR is an oncology-focused digital media company that provides news and information resources to oncology professionals.